Chenxi Liu

3.1k total citations
94 papers, 1.5k citations indexed

About

Chenxi Liu is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Chenxi Liu has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 20 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Chenxi Liu's work include Liver Disease Diagnosis and Treatment (11 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Chenxi Liu is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Chenxi Liu collaborates with scholars based in China, United States and Sweden. Chenxi Liu's co-authors include Yongzhe Li, Liubing Li, Linlin Cheng, Songxin Yan, Haizhen Chen, Haolong Li, Zhen Liu, Xiangyang Li, Cheng Xiao and Qiang Zhu and has published in prestigious journals such as Environmental Science & Technology, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Chenxi Liu

84 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenxi Liu China 18 371 366 267 218 211 94 1.5k
Satoshi Suzuki Japan 27 269 0.7× 236 0.6× 686 2.6× 103 0.5× 564 2.7× 124 2.2k
Ana Tobar Israel 22 229 0.6× 193 0.5× 645 2.4× 129 0.6× 192 0.9× 51 2.1k
James D. McFadyen Australia 19 264 0.7× 334 0.9× 390 1.5× 39 0.2× 232 1.1× 69 1.8k
Marcello Rattazzi Italy 25 283 0.8× 109 0.3× 410 1.5× 120 0.6× 340 1.6× 99 2.0k
Zongwen Shuai China 19 181 0.5× 209 0.6× 446 1.7× 39 0.2× 171 0.8× 81 1.5k
Pamir Atagündüz Türkiye 22 130 0.4× 582 1.6× 331 1.2× 65 0.3× 120 0.6× 64 1.7k
Federica D’Aurizio Italy 22 158 0.4× 92 0.3× 437 1.6× 411 1.9× 84 0.4× 60 1.4k
Erfan Nur Netherlands 20 94 0.3× 163 0.4× 310 1.2× 161 0.7× 125 0.6× 103 1.6k
Elsa Valderrama United States 27 240 0.6× 125 0.3× 527 2.0× 142 0.7× 392 1.9× 98 2.1k
Vanesa Bijol United States 26 148 0.4× 508 1.4× 808 3.0× 43 0.2× 435 2.1× 75 2.4k

Countries citing papers authored by Chenxi Liu

Since Specialization
Citations

This map shows the geographic impact of Chenxi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Liu more than expected).

Fields of papers citing papers by Chenxi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenxi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Liu. The network helps show where Chenxi Liu may publish in the future.

Co-authorship network of co-authors of Chenxi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenxi Liu. A scholar is included among the top collaborators of Chenxi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenxi Liu. Chenxi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, He, Debao Li, Qing Cui, et al.. (2025). Increased pulmonary blood flow leads to alveolar dysplasia during the early postnatal developmental stage. Cell & Bioscience. 15(1). 161–161.
2.
Liu, Chenxi, Jie Cheng, Zhongjian Shen, et al.. (2025). Baculoviruses manipulate host lipid metabolism via adipokinetic hormone signaling to induce climbing behavior. PLoS Pathogens. 21(1). e1012932–e1012932.
4.
Jiang, Jiafu, Chenxi Liu, Wei Jia, et al.. (2025). Characterization of the KNOX Gene Family in Regulating Alfalfa Compound Leaf Development. Journal of Plant Growth Regulation. 44(7). 3762–3777. 1 indexed citations
5.
Sun, Yiran, et al.. (2025). Angiogenin Ameliorates Endometritis by Inhibiting NLRP3 Inflammasome Activation. Animals. 15(14). 2002–2002. 1 indexed citations
6.
Liu, Haiyang, Qian Chen, Lili Wan, et al.. (2024). Mechanistic study of celastrol-mediated inhibition of proinflammatory activation of macrophages in IgA nephropathy via down-regulating ECM1. International Journal of Biological Sciences. 20(14). 5731–5746. 7 indexed citations
7.
Peng, Yi, et al.. (2023). Saa3 promotes pro-inflammatory macrophage differentiation and contributes to sepsis-induced AKI. International Immunopharmacology. 127. 111417–111417. 7 indexed citations
8.
Liu, Chenxi, et al.. (2023). Clinical and laboratory features of childhood-onset primary Sjögren's syndrome: A retrospective study from China. Frontiers in Pediatrics. 10. 1044812–1044812. 6 indexed citations
9.
Huang, Hua, Yingying Jin, Fei Ding, et al.. (2023). Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus. Lupus Science & Medicine. 10(1). e000834–e000834. 6 indexed citations
10.
Liu, Chenxi, Guang Song, Songxin Yan, et al.. (2023). Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis. Journal of Proteome Research. 22(10). 3254–3263. 4 indexed citations
11.
Yu, Zhen, Chenxi Liu, Xiaoyu Xie, et al.. (2022). EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli. Cell Death and Disease. 13(4). 351–351. 18 indexed citations
12.
Liu, Chenxi, Hui Ma, Xueqi Wang, et al.. (2022). Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure. European Radiology. 32(5). 3006–3015. 6 indexed citations
14.
Liu, Chenxi, Tiantian Liu, Miaomiao Tian, et al.. (2022). FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease. Free Radical Biology and Medicine. 193(Pt 2). 808–819. 41 indexed citations
15.
Guo, Di, Yijie Zhang, Su Zhang, et al.. (2021). Cholecystokinin-like peptide mediates satiety by inhibiting sugar attraction. PLoS Genetics. 17(8). e1009724–e1009724. 20 indexed citations
16.
Liu, Chenxi, Yan Sun, Yang Yao, et al.. (2021). Gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis. European Radiology. 31(8). 5840–5850. 12 indexed citations
17.
Wen, Xiaoting, Guang Song, Chaojun Hu, et al.. (2020). Identification of Novel Serological Autoantibodies in Takayasu Arteritis Patients Using HuProt Arrays. Molecular & Cellular Proteomics. 20. 100036–100036. 12 indexed citations
18.
Cheng, Linlin, Liubing Li, Chenxi Liu, Songxin Yan, & Yongzhe Li. (2020). Meta-analysis of anti- Saccharomyces cerevisiae antibodies as diagnostic markers of Behçet’s disease with gastrointestinal involvement. BMJ Open. 10(10). e033880–e033880. 10 indexed citations
19.
Li, Liubing, Chenxi Liu, Qian Wang, et al.. (2020). Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis. Journal of Clinical Laboratory Analysis. 34(8). e23307–e23307. 6 indexed citations
20.
Liu, Chenxi, Yong Hou, Yajun Yang, et al.. (2019). Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population. Clinica Chimica Acta. 491. 121–125. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026